3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
28
Melanoma
25
Carcinoma, Renal Cell
22
Lung Neoplasms
11
Neoplasm Metastasis
10
Squamous Cell Carcinoma of Head and Neck
9
Neoplasms
9
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Hodgkin Disease
8
Carcinoma, Transitional Cell
7
Carcinoma, Hepatocellular
7
Adenocarcinoma Of Esophagus
7
Triple Negative Breast Neoplasms
6
Stomach Neoplasms
6
Rectal Neoplasms
6
Ovarian Neoplasms
6
Pancreatic Neoplasms
5
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Nasopharyngeal Carcinoma
4
Multiple Myeloma
4
Endometrial Neoplasms
4
Carcinoma, Merkel Cell
4
Carcinoma, Basal Cell
4
Brain Neoplasms
4
Anus Neoplasms
4
Thyroid Neoplasms
3
Sarcoma, Kaposi
3
Recurrence
3
Interventions
Cisplatin
6
Paclitaxel
4
pembrolizumab
3
Fluorouracil
3
Carboplatin
3
tislelizumab
2
Taxes
2
Radiotherapy
2
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
Injections
2
Capecitabine
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
lenvatinib
1
durvalumab
1
cixutumumab
1
apatinib
1
Tegafur
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation
1
Levoleucovorin
1
Laparoscopy
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Fulvestrant
1
Docetaxel
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Nivolumab
×
30 days
×
Clear all
No trials found.